[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.108.182. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1989

Intravenous Immunoglobulin Therapy in Human Immunodeficiency Virus—Associated Thrombocytopenia-Reply

Arch Intern Med. 1989;149(2):467. doi:10.1001/archinte.1989.00390020151037

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.—With regard to Fisher's letter, we agree that outpatient therapy with intravenously administered immunoglobulin is both feasible and less costly than in-hospital treatment for human immunodeficiency virus—associated thrombocytopenia. Indeed, since publication of our article, we have treated some outpatients with intravenously administered immunoglobulin in a dose of 50 g given over a six-hour period as a single infusion, repeating this dose as clinically indicated.

First Page Preview View Large
First page PDF preview
First page PDF preview
×